Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.1M | $15.6M | $14.0M | $12.4M | $13.9M | $10.5M | $0 | $4.1M |
| Cost of revenue | $3.8M | $10.1M | $10.4M | $9.5M | $11.4M | $9.4M | $0 | $2.2M |
| Gross profit | $2.3M | $5.5M | $3.6M | $2.9M | $2.4M | $1.1M | $496.0K | −$384.0K |
| Gross margin | 37.7% | 35.0% | 25.9% | 23.5% | 17.6% | 10.1% | — | -9.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$8.3M | −$13.6M | −$8.2M | −$6.9M | −$6.6M | −$4.8M | −$3.8M | −$7.0M |
| EBITDA | −$7.9M | −$10.9M | −$6.3M | −$3.5M | −$12.7M | −$5.1M | −$3.8M | −$12.6M |
| Net income | −$9.0M | −$16.9M | −$9.9M | −$4.5M | −$16.3M | −$7.5M | −$3.8M | −$16.6M |
| Net margin | -147.8% | -108.4% | -70.4% | -36.2% | -117.2% | -71.8% | — | -408.0% |
| EPS (diluted) | -29.79 | -28.17 | -19.67 | -7.10 | -21.41 | -7.04 | 0.00 | -0.84 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $27M | $0.15 | $0.15–$0.15 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds EAST.
No tracked institution reports a position in EAST as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-05-15 | 1-for-20reverse |
No one on the platform has traded EAST yet.
| $2M |
| — |
| RGFThe Real Good Food Company, Inc. | $1.25 | +100.00% | $2M | — |
| SRXHSRx Health Solutions Inc. | $0.09 | +0.00% | $3M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at NaN× sales vs its 0.8× historical median P/S.
Fair value ≈ $-1.05 · price $0.89 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.